Mark Andrew White

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Andrew White:

Company Role Class Num Shares Value Price $ Report Date Ownership
ROCKET PHARMACEUTICALS, INC. General Manager, Commercial Affairs Common Stock 69,140 $1,149,453 $16.62 31 Oct 2024 Direct
ROCKET PHARMACEUTICALS, INC. General Manager, Commercial Affairs Stock Option (Right to Buy) 32,727 $410,724 $12.55 16 Feb 2024 Direct

Insider Reports Filed by Mark Andrew White

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCKT ROCKET PHARMACEUTICALS, INC. 31 Oct 2024 1 -$51,205 4 General Manager, Commercial Affairs 04 Nov 2024, 16:06
RCKT ROCKET PHARMACEUTICALS, INC. 08 Jul 2024 1 -$61,715 4 General Manager, Commercial Affairs 09 Jul 2024, 16:05
RCKT ROCKET PHARMACEUTICALS, INC. 08 Apr 2024 1 -$308,763 4 General Manager, Commercial Affairs 10 Apr 2024, 20:39
RCKT ROCKET PHARMACEUTICALS, INC. 16 Feb 2024 2 $0 4 Chief Medical Officer 21 Feb 2024, 20:54
RCKT ROCKET PHARMACEUTICALS, INC. 04 Apr 2023 2 $0 4 Chief Medical Officer 12 Apr 2023, 19:00
RCKT ROCKET PHARMACEUTICALS, INC. 04 Apr 2023 0 $0 3 Chief Medical Officer 12 Apr 2023, 18:47